Nureca

Nureca

317.70
-1.54
(-0.48%)
hide
Key Fundamentals
Add Ratio
Market Cap
317.71 Cr
EPS
0.85
PE Ratio
77.62
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
447.50
52 Week Low
203.62
PB Ratio
1.61
Debt to Equity
0.02
Forecast For
Actual

Company News

View All News
Caret
positive
Nureca Limited received SEBI approval on October 16, 2025, for exemption from Regulation 24(ii) of Buy-Back Regulations, allowing the company to proceed with a share buyback while a merger scheme with its wholly owned subsidiary Nureca Technologies Private Limited is pending before the National Company Law Tribunal. The Board of Directors had approved the merger scheme on May 20, 2025, and shareholders approved it on June 16, 2025. SEBI granted the exemption considering that the internal restructuring involves no new equity issuance or change in shareholding pattern. The company's promoters have committed not to participate in the buyback, making it exclusively for public shareholders. The board will consider the buyback proposal at an appropriate time and comply with all applicable regulations.
positive
Nureca Limited, a home healthcare and wellness company, announced its financial results for Q2 FY26 ended September 30, 2025. The company reported revenue of ₹37.7 crore in Q2 FY26, representing 21% year-over-year growth from ₹31.2 crore in Q2 FY25. For H1 FY26, revenue reached ₹71.9 crore, marking 40% growth from ₹51.5 crore in H1 FY25. Operating profits surged 239% year-over-year to ₹3.3 crore compared to ₹(2.4) crore in the same quarter last year. Profit after tax increased significantly to ₹3.6 crore from ₹(0.5) crore in Q2 FY25. The company attributed the performance to focused cost optimization and growth in quick commerce sales channels. Nureca operates as a digital-first healthcare company with over 93% revenue generated through online sales and maintains a debt-free, asset-light business model.
neutral
Nureca Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The board meeting was held on October 16, 2025, commencing at 4:00 PM and concluding at 5:15 PM. The company operates in the home healthcare and wellness products business segment. During the quarter, Nureca filed a Scheme of Merger by Absorption for its wholly owned subsidiary Nureca Technologies Private Limited, effective from April 1, 2025, subject to regulatory approvals. The company also filed Form STK-2 for striking off its wholly owned subsidiary Nureca Healthcare Private Limited under Section 248 of the Companies Act, 2013, resulting in a write-off of investment of Rs 0.01 million. The results were reviewed by the Audit Committee and received limited review from statutory auditors.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,936.40
#1 19,620.71
54.85
#1 1,759.00
22.62
#1 339
25.81
46.33
315.05
1,731.58
75.17
242.40
24.12
25
-50.60
39.29
290.70
1,546.71
55.94
408.40
32.64
30
-55.00
24.17
598.00
993.98
62.04
249.37
40.00
17
-20.59
51.82
601.40
970.01
53.40
186.60
40.62
20
20.00
52.67
510.00
605.30
32.04
67.10
13.15
18
18.92
35.80
266.00
493.10
#1 30.61
136.30
#1 107.77
16
50.00
49.41
317.70
#8 317.71
#10 77.62
#7 122.10
#7 19.24
#10 1
#1 820.00
77.90
281.20
309.00
38.44
111.80
-1.43
8
0.00
9.27
268.00
281.76
37.85
89.85
0.60
7
752.54
41.37
Growth Rate
Revenue Growth
19.24 %
Net Income Growth
-144.44 %
Cash Flow Change
-604.06 %
ROE
-147.31 %
ROCE
-222.86 %
EBITDA Margin (Avg.)
1,236.67 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
33
30
93
60
33
122
49
50
43
27
39
30
23
24
35
28
16
26
34
28
34
37
40
Expenses
29
17
56
52
28
72
41
43
44
31
42
29
25
24
30
27
21
23
34
31
31
35
35
EBITDA
4
13
37
9
6
49
8
7
-1
-5
-3
1
-1
-0
5
2
-6
3
1
-3
3
2
6
Operating Profit %
11 %
43 %
39 %
13 %
14 %
39 %
13 %
11 %
-7 %
-22 %
-13 %
-3 %
-16 %
-14 %
4 %
-19 %
-26 %
-12 %
-8 %
-15 %
4 %
-2 %
9 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
Profit Before Tax
3
13
36
9
5
49
8
6
-2
-5
-4
0
-2
-1
4
1
-7
3
-0
-3
2
1
5
Tax
1
3
9
2
1
13
2
2
-1
-1
-1
0
-0
-0
1
1
-2
1
0
-1
-0
0
1
Net Profit
2
9
27
6
4
36
5
5
-1
-4
-3
0
-2
-1
3
0
-4
2
-1
-3
3
1
4
EPS in ₹
3.40
13.50
38.19
8.53
4.56
36.20
5.43
4.73
-1.40
-4.13
-2.89
0.30
-1.53
-0.71
2.90
0.16
-4.15
1.66
-0.48
-2.80
2.47
0.81
3.63

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
24
34
186
219
207
205
210
Fixed Assets
1
1
4
10
9
7
9
Current Assets
23
33
181
206
187
193
190
Capital Work in Progress
0
0
0
0
0
0
0
Investments
0
0
0
33
59
94
1
Other Assets
23
33
182
175
139
104
200
Total Liabilities
24
34
186
219
207
205
210
Current Liabilities
15
10
19
12
9
9
12
Non Current Liabilities
0
9
4
4
3
3
3
Total Equity
8
15
163
203
195
193
194
Reserve & Surplus
8
15
153
193
185
183
184
Share Capital
0
0
10
10
10
10
10

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
17
-9
-8
14
-11
Investing Activities
-0
-0
-110
-3
-17
18
8
Operating Activities
0
-8
35
1
10
-3
-19
Financing Activities
-0
8
92
-7
-2
-1
-0

Share Holding

% Holding
Jan 2020
Feb 2021
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
93.33 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
62.98 %
62.98 %
62.98 %
63.24 %
63.24 %
63.24 %
63.24 %
63.77 %
64.06 %
64.30 %
64.33 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.10 %
0.00 %
0.08 %
0.08 %
0.69 %
0.36 %
1.07 %
0.08 %
DIIs
0.00 %
3.54 %
5.71 %
5.40 %
5.42 %
5.43 %
5.23 %
5.23 %
0.58 %
0.03 %
0.02 %
0.02 %
0.02 %
0.00 %
0.02 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.87 %
4.49 %
4.32 %
5.50 %
5.18 %
8.49 %
8.54 %
25.85 %
34.17 %
34.06 %
34.24 %
34.32 %
33.61 %
33.73 %
34.24 %
32.97 %
33.27 %
32.39 %
33.12 %
Others
6.67 %
20.59 %
19.80 %
20.28 %
19.07 %
19.40 %
16.29 %
16.23 %
3.57 %
2.82 %
2.94 %
2.76 %
2.33 %
3.16 %
2.94 %
2.41 %
2.53 %
2.27 %
2.20 %
2.45 %
No of Share Holders
19
8,436
7,827
10,060
12,618
15,471
26,123
26,114
63,911
62,007
58,560
55,569
52,255
49,600
45,996
43,813
41,986
41,314
39,304
38,075

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 2 3 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.15 1 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Sept 2021 DIVIDEND Dividend
₹ 2.00 /share
21 Sept 2021 1,549.00 1,634.10
25 Feb 2022 DIVIDEND Dividend
₹ 3.00 /share
24 Feb 2022 1,591.15 1,300.35
18 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Jul 2024 277.90 275.50
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 299.65 299.35
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 389.15 360.70
05 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 May 2025 248.00 228.80
16 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jun 2025 228.80 279.00
15 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 Jul 2025 285.40 288.80
16 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 Oct 2025 229.70 235.45

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Intimation Of Securities And Exchange Board Of India (SEBI) Order Under Section 11(1) Of SEBI Act 1992 Read With Regulation 28 Of SEBI (Buy-Back Of Securities) Regulations 2018 (Buy-Back Regulations)5 days ago
Nureca Limted Has Informed The Exchange Regarding Financial Results For The Quarter And Half Year Ended 30Th September2025.6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation6 days ago
Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Financial Results For The Quarter And Half Year Ended 30Th September2025.6 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementOct 11, 2025
Board Meeting Intimation for Nureca Limited Has Informed The Exchange Regarding Intimation Of Board Meeting For The Declaration Of Quarterly Results And Other Business Matters.Oct 10, 2025
Closure of Trading WindowSep 29, 2025
Filing Of Scheme Under Regulation 37(6) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jul 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 15, 2025
Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Unaudited Financial Results For The Quarter Ended 30Th June2025.Jul 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Board Meeting Intimation for Declaration Of Unaudited Standalone/Consolidated Financial Results For The Quarter Ended June 302025 Alongwith Other Business Matters .Jul 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 08, 2025
Closure of Trading WindowJun 28, 2025
Closure of Trading WindowJun 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 17, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 17, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJun 16, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
Notice Of Annual General Meeting To Be Held On 16Th June2025May 23, 2025
Annual ReportMay 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2025
Announcement Under Regulation 30May 20, 2025
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 06, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 06, 2025
Announcement under Regulation 30 (LODR)-CessationMay 06, 2025
Book ClosureMay 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 05 MAY 2025May 05, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2025
Business UpdateApr 29, 2025
Board Meeting Intimation for Consider And Approve Inter-Alia The Audited Financial Results (Standalone And Consolidated) Along With Other Business Matters For The Fourth Quarter And Full Year Ended On March 31 2025.Apr 28, 2025
Nureca Limited Has Informed The Exchange Regarding Business Update .Apr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Business UpdateApr 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 12, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 01, 2025
Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015.Mar 31, 2025

Technical Indicators

RSI(14)
Neutral
76.75
ATR(14)
Volatile
15.94
STOCH(9,6)
Neutral
74.70
STOCH RSI(14)
Overbought
94.08
MACD(12,26)
Bullish
10.58
ADX(14)
Strong Trend
28.32
UO(9)
Bearish
68.74
ROC(12)
Uptrend And Accelerating
33.98
WillR(14)
Neutral
-20.45